-
3 new Ebola vaccines are being fast-tracked amid the current outbreak — when could they be ready?The Bundibugyo virus driving the current Ebola outbreak has no approved vaccine, but researchers are leveraging decades of vaccine innovation in an effort to change that.
medicine-drugs -
A cheap arthritis drug shows promise treating RSV in early studyAn arthritis drug reduces the amount of RSV in human respiratory cells, but experts say it's too early to say if it will actually treat the common infection.
medicine-drugs -
'It's being promoted like there's absolutely no risk': Why some experts say melatonin should be considered a drug rather than a supplementAnalysis Researchers want stricter testing, better labels and accurate dosages for a wildly popular sleep aid that comes with some risks.
2 CommentsAnalysis -
An infant's brown eyes turned indigo after COVID antiviral treatmentDiagnostic dilemma In a visually striking medical case, a baby's eyes changed color while he was receiving care in a hospital.
Diagnostic dilemma -
A woman turned black and blue weeks after starting a new medicationA woman's sudden hyperpigmentation was a side effect of a medicine she was taking.
2 Commentsmedicine-drugs -
Early data links Wegovy to risk of 'eye stroke' — here's what to knowA rare form of vision loss has been linked to certain GLP-1s, but more so to Wegovy than to other weight-loss drugs in this class. Should you worry?
medicine-drugs -
New blood test aims to spot liver scarring before it paves the way to cancerLiver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.
medicine-drugs -
New pain-relief opioid could be much less addictive than morphine, rodent study findsA new and potentially safer opioid has been tested in lab rats, and the results suggest it relieves pain with a lower risk of addiction than other drugs in its class.
3 Commentsmedicine-drugs -
Experimental drug doubles one-year survival in pancreatic cancerA new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those with advanced pancreatic cancer in a trial.
2 Commentsmedicine-drugs
